| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 158.328 | 331.328 | 494.519 | 584.934 |
| Total Income - EUR | - | - | - | - | - | - | 163.270 | 331.328 | 494.519 | 585.388 |
| Total Expenses - EUR | - | - | - | - | - | - | 76.117 | 169.741 | 266.645 | 398.341 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 87.153 | 161.588 | 227.874 | 187.047 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 85.904 | 158.772 | 223.608 | 172.557 |
| Employees | - | - | - | - | - | - | 2 | 3 | 3 | 5 |
Check the financial reports for the company - Roaxis Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 102.109 | 84.952 | 96.062 | 168.784 |
| Current Assets | - | - | - | - | - | - | 40.527 | 201.193 | 192.112 | 290.673 |
| Inventories | - | - | - | - | - | - | 2.077 | 1.407 | 1.761 | 19.338 |
| Receivables | - | - | - | - | - | - | 3.454 | 115.318 | 59.843 | 119.093 |
| Cash | - | - | - | - | - | - | 34.996 | 84.467 | 130.507 | 152.241 |
| Shareholders Funds | - | - | - | - | - | - | 85.813 | 158.969 | 247.068 | 203.664 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 56.823 | 127.176 | 41.105 | 252.363 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 4.699 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Roaxis Medical S.r.l.